
Ion Beam Applications SA
XBRU:IBAB

Net Margin
Ion Beam Applications SA
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
BE |
![]() |
Ion Beam Applications SA
XBRU:IBAB
|
344m EUR |
2%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
238.1B USD |
32%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
187.5B USD |
28%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
154.5B USD |
12%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
150B USD |
12%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
110.7B USD |
14%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
52.7B EUR |
9%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
49.3B USD |
7%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
45.2B USD |
75%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.8B USD |
23%
|
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
277.7B CNY |
31%
|
Ion Beam Applications SA
Glance View
Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon. IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.

See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Ion Beam Applications SA's most recent financial statements, the company has Net Margin of 1.9%.